Patients enrolled in the BS054 clinical trial and treated with BS054 combined with coli embolization
Conditions
Interventions
Intervention type:
Name of intervention:
Dose form / Japanese Medical Device Nomenclature:
Route of administration / Site of application:
Dose per administration:
Dosing frequency / Frequency of use:
Sponsors
Kobe City Hospital Organization General Hospital
Nobuyuki Sakai
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients enrolled in the BS054 clinical trial and treated with BS054 combined with coli embolization. Patients willing to accept follow-up visits and examinations. Patients understand this study and able to give written Informed Consent.
Exclusion criteria
Exclusion criteria: No
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| modified Rankin Scale at 2 years after BS054 stent implantation | — |
Secondary
| Measure | Time frame |
|---|---|
| Patency rate at 2 years after BS054 stent implantation Intra-aneurysm blood flow at 2 years after BS054 stent implantation Recanalization and regrowth of aneurysm within two years after BS054 stent implantation Retreatment within 2 years after BS054 stent implantation Adverse event or Malfunction within 2 years after BS054 stent implantation | — |
Countries
Japan
Contacts
Public ContactChiaki Sakai, Chun Hee Kim
Kobe City Hospital Organization General Hospital
Outcome results
None listed